• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec24
WuXi Biologics Wins 2025 Hong Kong ESG Report Award
03:55
Dec19
WuXi Biologics Receives CDP Climate Change and Water Security 'A' Rating
04:26
Dec2
WuXi Biologics Signs Strategic Cooperation Memorandum with Qatar Free Zone Authority
04:22
Nov29
WuXi Biologics and Its Subsidiary Donate HKD 10 Million for Disaster Relief
07:20
Nov28
WuXi Biologics Issues 10.369 Million Shares Under Share Plan
13:09
Nov25
WuXi XDC Cayman to Hold Special Shareholders Meeting to Discuss Service Agreements with WuXi Biologics and WuXi AppTec
22:56

Schedules & Filings

Schedules
Filings
Aug19
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 5.447 B, Net Income 1.28 B, EPS 0.3019

Mar25
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 5.373 B, Net Income 987.79 M, EPS 0.2324

Aug21
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 4.607 B, Net Income 805.4 M, EPS 0.1871

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
06038
0.425
+32.81%
+0.105
08635
0.570
+28.09%
+0.125
08573
0.053
+26.19%
+0.011
03830
0.080
+25.00%
+0.016
01570
6.170
+23.40%
+1.170
02315
35.080
+22.23%
+6.380
01875
2.500
+19.05%
+0.400
00145
0.265
+17.78%
+0.040
02330
0.226
+17.71%
+0.034
00209
0.173
+16.89%
+0.025
View More